Compound class:
Synthetic organic
Comment: This compound is reported as a selective, allosteric inhibitor of SARS-CoV-2 nsp13 helicase activity [1]. It covalently modifies Cys556 of nsp13, which is distal from its ATP- or RNA-binding sites. Compound 4b has little inhibitory activity on the unwinding function of the human RecQ helicases BLM RecQ like helicase (BLM) and WRN RecQ like helicase (WRN).
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|